Moberg Pharma AB (publ) (MOB) — Capital Reinvestment Ratio
Moberg Pharma AB (publ) (MOB) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr1.52 Million) in capital expenditures (Skr1.52 Million). See MOB net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Moberg Pharma AB (publ) Capital Reinvestment Ratio (2012–2019)
This chart tracks Moberg Pharma AB (publ)'s Capital Reinvestment Ratio across 6 annual periods. Check MOB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Moberg Pharma AB (publ) (2012–2019)
Year-by-year Capital Reinvestment Ratio for Moberg Pharma AB (publ) from 2012 to 2019. For live market cap and broader valuation context, see Moberg Pharma AB (publ) market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.73x | Skr3.95 Million | Skr2.87 Million | ▼ -35.8% |
| 2018 | 1.13x | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.37x | Skr53.82 Million | Skr19.68 Million | ▼ -74.4% |
| 2015 | 1.43x | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr9.48 Million | Skr630.00K | — |